GleamWall
中文EN

STAA STAAR SURGICAL CO

Ophthalmic Goods · Nasdaq · SEC CIK 718937 · Fiscal year ends 01/02

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY42.4%
TTM net income YoY100.5%
TTM EPS YoY100.5%
Revenue 3-yr CAGR1.9%
Net income 3-yr CAGR-69.9%

Margins

Gross margin73.6%
Operating margin0.2%
Net margin0.2%
FCF margin5.4%
EBITDA margin2.9%

Returns

ROE0.1%
ROA0.1%
ROIC (approx.)0.2%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets22.5%
Debt / equity0.00x
Current ratio4.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income40.37x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252026-01-02FY20242024-12-27
Income statement
Revenue$239.44M$313.90M
Cost of revenue$57.02M$74.32M
Gross profit$182.42M$239.58M
R&D expense$40.05M$45.32M
SG&A expense$274.13M$252.19M
Operating income-$91.71M-$12.61M
Pretax income-$82.26M-$9.05M
Income tax-$1.81M$11.16M
Net income-$80.45M-$20.21M
EBITDA-$83.39M-$5.72M
EPS (basic)-1.62-0.41
EPS (diluted)-1.62-0.41
Weighted avg. shares (diluted)49.57M49.12M
Balance sheet
Cash & equivalents$153.15M$144.16M
Short-term investments$34.39M$86.33M
Receivables$50.06M$77.90M
Inventory$58.42M$44.58M
Current assets$311.55M$367.94M
PP&E, net$73.32M$84.89M
Goodwill$1.79M$1.79M
Total assets$451.68M$509.52M
Current liabilities$68.50M$70.31M
Total liabilities$107.49M$112.19M
Shareholders' equity$344.18M$397.33M
Shares outstanding49.40M49.29M
Cash flow statement
Operating cash flow-$34.23M$15.72M
Capital expenditure$5.82M$23.39M
Free cash flow-$40.05M-$7.67M
Investing cash flow$46.34M-$59.22M
Financing cash flow-$4.55M$5.72M
Depreciation & amortization$8.32M$6.89M
Stock-based compensation$30.59M$27.21M
Share buybacks$6.46M—

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.